Patent · US Expired

Optically active thiazolidinone derivative

US5925658A · kind A · utility

1Cited by
27References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 2, 1997
Grant dateJul 20, 1999
Priority date
Expiry dateSep 2, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D277/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

An optically active thiazolidinone derivative having the general formula: ##STR1## wherein: R.sup.1 represents a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group, a phenyl group, a substituted phenyl group (said substituent represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen), a phenyl-C.sub.1 -C.sub.2 alkyl group or a substituted phenyl-C.sub.3 -C.sub.2 alkyl group (the substituent of said phenyl represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen); R.sup.2 represents a C.sub.1 -C.sub.6 alkyl group; and n represents 1 or 2!. Effect The optically active thiazolidinone derivative of the present invention has excellent anti-angina pectoris action and is useful as a preventive agent or a therapeutic agent for angina pectoris.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.